Ownership and insider activity for Bausch + Lomb Corporation (BLCO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options.
Price
| Price | $20.00 (closing price, October 30, 2026) |
| Market Cap | $7.1B |
| Exchange | NYSE |
| Country | CA |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-12 | Trebbi Barbara | A-Award | 11,776 | |
| 2026-08-05 | Trebbi Barbara | |||
| 2026-08-12 | PAUL LAURENCE E | A-Award | 11,776 | |
| 2026-08-05 | PAUL LAURENCE E | |||
| 2026-08-12 | Chersi Robert J | A-Award | 11,776 | |
| 2026-08-05 | Chersi Robert J | |||
| 2026-08-05 | APPIO THOMAS | |||
| 2026-08-10 | Munsch Frederick | S-Sale | 52,900 | $888K |
| 2026-08-06 | VON ESCHENBACH ANDREW C. | S-Sale | 12,500 | $206K |
| 2026-08-07 | VON ESCHENBACH ANDREW C. | S-Sale | 6,059 | $100K |
Balance Sheet (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192.0M | $238.0M | $174.0M | $380.0M | $334.0M | $305.0M | $383.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $713.0M | $645.0M | $721.0M | $726.0M | $875.0M | $1.03B | $1.22B |
| Inventory | $592.0M | $616.0M | $572.0M | $628.0M | $1.03B | $1.04B | $976.0M |
| Total Current Assets | $1.70B | $1.65B | $1.64B | $2.14B | $2.74B | $2.79B | $2.98B |
| Property, Plant & Equipment | $1.09B | $1.26B | $1.23B | $1.42B | $1.50B | $1.49B | $1.76B |
| Goodwill | $4.55B | $4.68B | $4.59B | $4.51B | $4.58B | $4.52B | $4.76B |
| Intangible Assets | $2.85B | $2.56B | $2.26B | $2.06B | $3.59B | $3.49B | $3.28B |
| Total Assets | $11.47B | $11.27B | $10.82B | $11.14B | $13.44B | $13.47B | $14.02B |
| Accounts Payable | $262.0M | $178.0M | $239.0M | $317.0M | $522.0M | $389.0M | $388.0M |
| Short-term Debt | $16.0M | $18.0M | $28.0M | $51.0M | $57.0M | $40.0M | $77.0M |
| Total Current Liabilities | $1.03B | $909.0M | $1.10B | $1.30B | $1.58B | $1.74B | $1.92B |
| Long-term Debt | 0 | 0 | 0 | $2.41B | $4.53B | $4.74B | $5.17B |
| Total Liabilities | $1.44B | $1.28B | $1.42B | $4.04B | $6.52B | $6.92B | $7.50B |
| Retained Earnings | 0 | 0 | 0 | $6.0M | -$254.0M | -$571.0M | -$931.0M |
| Total Equity | $9.96B | $9.92B | $9.33B | $7.03B | $6.85B | $6.47B | $6.45B |
| Total Debt | $93.0M | $101.0M | $140.0M | $2.55B | $4.68B | $4.94B | $5.37B |
| Net Debt | -$99.0M | -$137.0M | -$34.0M | $2.17B | $4.34B | $4.63B | $4.99B |
| Working Capital | $660.0M | $745.0M | $536.0M | $841.0M | $1.16B | $1.05B | $1.06B |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 1.56 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 0.89 |
Profitability
| Return on Equity | -1.73% |
| Return on Invested Capital | 3.78% |
| Return on Assets | -0.80% |
| Gross Margin | 58.62% |
| Operating Margin | 8.41% |
| Net Margin | -2.05% |
Related companies: ARWR · PCVX · PTCT · TGTX · CRSP · MMSI · GKOS
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of BLCO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks